What is the recommended regimen of Keflex (cephalexin) for treating an infected ingrown great‑toe nail?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Keflex for Infected Ingrown Great Toe Nail

For an infected ingrown toenail, definitive treatment is nail border removal (partial nail avulsion with phenolization), and antibiotics are NOT necessary as they do not improve healing time or outcomes 1, 2.

When Antibiotics Are Actually Indicated

The evidence is clear that oral antibiotics should be reserved for specific high-risk situations, not routine infected ingrown toenails:

  • Cellulitis extending proximal to the hallux interphalangeal joint (beyond the toe itself) 3
  • Systemic signs of infection (fever, chills, systemic inflammatory response) 3
  • Immunocompromised states 1
  • Peripheral vascular disease 1

A prospective randomized trial demonstrated that patients receiving chemical matrixectomy alone healed in 2.0 weeks versus 1.9 weeks with simultaneous antibiotics—no clinically meaningful difference 1. Another randomized trial confirmed that local antibiotics after nail procedures provided no benefit in reducing infection signs or recurrence 4.

If Antibiotics Are Truly Needed (Cellulitis Present)

When cellulitis extends beyond the toe or systemic signs are present, treat as a non-purulent skin and soft tissue infection:

Dosing Regimen from FDA Label:

  • Standard dose: Cephalexin 500 mg every 6 hours (four times daily) 5
  • Alternative for skin infections: 500 mg every 12 hours (twice daily) is FDA-approved for uncomplicated skin and soft tissue infections 5
  • Duration: 5-7 days based on clinical response 3, 5

Practical Considerations:

  • The FDA label explicitly states 500 mg every 12 hours is acceptable for skin and soft tissue infections 5
  • Recent pediatric data supports less frequent dosing (BID/TID) for improved adherence 6
  • For severe infections or less susceptible organisms, higher doses may be needed 5

Common Pitfalls to Avoid

Do not prescribe antibiotics reflexively for infected ingrown toenails. The infection is localized to the nail fold, and the inflammatory response resolves with mechanical removal of the offending nail border. Unnecessary antibiotic use contributes to resistance without clinical benefit 1, 2.

If prescribing cephalexin, ensure adequate dosing. The standard 500 mg QID remains the most conservative approach 5, though 500 mg BID is FDA-approved for skin infections and may improve adherence 5.

Refer for definitive treatment. Partial nail avulsion with phenolization has superior outcomes compared to antibiotics alone, with recurrence rates significantly lower than matrix excision 2, 4.

Clinical Algorithm

  1. Assess extent of infection:

    • Localized to nail fold only → Nail procedure WITHOUT antibiotics
    • Cellulitis beyond interphalangeal joint OR systemic signs → Nail procedure WITH antibiotics
  2. If antibiotics indicated:

    • Cephalexin 500 mg every 6 hours × 5-7 days (standard) 5
    • OR 500 mg every 12 hours × 5-7 days (acceptable alternative) 5
  3. Arrange definitive treatment: Partial nail avulsion with phenolization 2, 4

The IDSA guidelines support treating non-purulent cellulitis with agents active against streptococci, with cephalexin being appropriate for MSSA coverage when indicated 3. However, the specific evidence for ingrown toenails demonstrates that the procedure itself—not the antibiotic—drives clinical improvement 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.